Search Results
531 results
Your search is now limited to «Hypertension» expert search.
Treatment-naïve patients with stage 1 hypertension received lercanidipine 10 mg and patients with stage 2 received lercanidipine 10 mg/enalapril 10 mg.
More from International Journal of COPD:
MedPageToday.com 01/21/2019 15:00
You have somebody with HFpEF, but boy, they have really severe pulmonary hypertension, or they have mitral valve disease and they have really severe pulmonary hypertension, or they have COPD and emphysema, but out of proportion pulmonary hypertension.
More from MedPageToday.com:
ClinicalTrials.gov 01/21/2019 12:00
The risk of strokes is strongly related to poorly controlled hypertension.
More from ClinicalTrials.gov:
Pulmonology Advisor 01/21/2019 07:00
Antiphospholipid (aPL) antibodies are commonly found in patients with chronic thromboembolic pulmonary hypertension (CTEPH), and may be predictive biomarkers for the disease.
More from Pulmonology Advisor:
FeedNavigator 01/20/2019 12:03
There was no benefit of ACEi in males, but a probable benefit on diabetes/hypertension events.
More from FeedNavigator:
Medindia.com 01/19/2019 06:54
This is a striking result, especially given the very short time frame in which control was reached: an average of seven weeks," said corresponding author Naomi Fisher, MD, director of the Hypertension Service and Hypertension Specialty Clinic at the Brigham.
More from Medindia.com:
Technology Org 01/18/2019 15:49
Hundreds of thousands of deaths every year can be traced back to hypertension, better known simply as high blood pressure.
More from Technology Org:
Healio News 01/18/2019 08:29
If the home BP remained elevated after the prescription of three medications, including a diuretic, patients were diagnosed with resistant hypertension and were then referred to a hypertension specialist.
More from Healio News:
Benzinga 01/17/2019 08:06
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak. (Biotech stocks hitting 52-week highs on Jan. 16). Avenue Therapeutics Inc (NASDAQ: ATXI ). BioDelivery Sciences International, Inc. (NASDAQ: BDSI ). ResMed Inc. (NYSE: RMD ). Down In The Dumps. (Biotech stocks hitting 52-week lows on Jan. 16). Amneal Pharmaceuticals Inc (NYSE: AMRX ). Aptinyx Inc (NASDAQ: APTX )(reported a mid-stage trial that evaluated NYX-2925, its treatment candidate for patients with painful diabetic peripheral neuropathy, did not meet the primary endpoint). Bio-Path Holdings Inc (NASDAQ: BPTH ). Ligand Pharmaceuticals Inc. (NASDAQ: LGND ) (short seller Citron Research said there is likely to be 80-percent downside in the stock fr.
European Respiratory Journal 01/17/2019 04:44
Portopulmonary hypertension (PoPH) and hepatopulmonary syndrome (HPS) are rare pulmonary vascular complications of portal hypertension [1]. In PoPH, pulmonary vascular resistance (PVR) is elevated, resulting in heightened right ventricular workload which may lead to right-sided heart failure. HPS is characterised by progressive hypoxaemia due to diffusion–perfusion mismatching caused by regional, mostly basilar, intrapulmonary vascular dilatations of capillary and pre-capillary vessels. The exact pathogenesis of both conditions is unclear, as is the underlying predisposition causing a small proportion of patients with liver disease to develop PoPH or HPS.
More from European Respiratory Journal:
BIOENGINEER.ORG 01/16/2019 19:40
Scientists have pinpointed cells in the immune system that could be key to tackling high blood pressure.
More from BIOENGINEER.ORG:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications